SNCA and Parkinson disease: Considering the roles of alpha-synucleine aggregation and dopamine decline in PD [38], we studied these 48 genes in reference to alteration in transgenic expression of human α-Synuclein and behavioural assays that are governed by the dopamine-signalling pathway, to perform a screening of those genes that affect these parameters.